Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |